Recent Press Releases

STALLERGENES And ActoGenix To Develop An Innovative New Class Of Oral Allergy Treatments

STALLERGENES exercised option to pursue the exclusive development of application of ActoGeniX's technology for targeted delivery of allergen-based treatments ANTONY, France and GHENT, Belgium,...

AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center

FREDERICK, Md.--AstraZeneca today announced plans to expand its biologics manufacturing center in Frederick, Md. The more than $200 million project will increase production capacity at the facility...

Neothetics Prices Initial Public Offering

SAN DIEGO -- Neothetics, Inc. (NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the pricing of its initial public offering of...

SEC Suspends Trading in Companies Touting Operations Related to Prevention or Treatment of Ebola

Agency Issues Investor Alert Warning of Fraud Risks in Thinly-Traded Stocks of Companies Linking Future Business Prospects to Ebola Outbreak Washington D.C., Nov. 20, 2014 — The Securities and...

Scholar Rock Appoints Gregory J. Carven, PhD, as Vice President of Antibody Discovery and Protein Sciences

Discovery Leader with Accomplished Track Record of Discovering Breakthrough Medicines from Invention to IND Filing CAMBRIDGE, Mass., Nov. 20, 2014 – Scholar Rock, a biotechnology company...

James W. Burns, Ph.D., - Head of the Sanofi Genzyme R&D Center, Global R&D, effective as of December 1st

James W. Burns, Ph.D., - Head of the Sanofi Genzyme R&D Center, Global R&D, effective as of December 1st. Jim will continue to be based in Boston and will remain as interim Head of the Sanofi...

Novartis Cosentyx(TM) receives positive CHMP opinion for first-line treatment of moderate-to-severe psoriasis patients

Cosentyx (secukinumab, formerly AIN457) is recommended as first-line systemic therapy for the treatment of moderate-to-severe plaque psoriasis in adult patients in Europe In Phase III studies,...

Nopras Technologies, Inc. Appoints Director Of Business Development - East Coast Operations

NOVI, Mich., Nov. 17, 2014 /PRNewswire/ -- Nopras Technologies (www.nopras-tech.com) has announced the appointment of Stewart B. Rosenberg to the position of Director, Business Development East Coast...

Anterios Hires Fabian Tenenbaum As Chief Financial Officer And Chief Business Officer

NEW YORK, Nov. 17, 2014 /PRNewswire/ -- Anterios, Inc., a privately held medical dermatology and aesthetic medicine biopharmaceutical company, announced today that it has hired Fabian Tenenbaum to...

Seres Health Appoints Biotechnology Finance Leader Eric Shaff As Chief Financial Officer

CAMBRIDGE, Mass., Nov. 17, 2014 /PRNewswire/ -- Seres Health, Inc., a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced...

Intercept Pharmaceuticals (ICPT) Appoints Lisa Bright As Head Of Europe

NEW YORK and LONDON, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel...

PTC Therapeutics, Inc. (PTCT) Appoints Dr. Tuyen Ong SVP, Head Of Clinical Development And Translational Research

SOUTH PLAINFIELD, N.J., Nov. 17, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Tuyen Ong, M.D., MRCOphth, MBA, as Senior Vice President, Head of...

Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President Of Medical Affairs

STAMFORD, Conn., Nov. 17, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the...

Retrophin Names Laura M. Clague as Chief Financial Officer

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced the appointment of Laura M. Clague, CPA as Senior Vice President and Chief Financial Officer, effective immediately. Ms....

XRpro Appoints Richard Cunningham President And CEO

CAMBRIDGE, Mass., Nov. 17, 2014 /PRNewswire/ -- Caldera Pharmaceuticals, Inc., d/b/a XRpro ("XRpro") , a provider of a unique platform for drug discovery and development services which...

Ablynx (ABLYF) Appoints Johan Heylen As Chief Commercial Officer

GHENT, Belgium, 18 November 2014 - Ablynx [Euronext Brussels: ABLX] today announced the appointment of Johan Heylen as Chief Commercial Officer. Mr Heylen will assume responsibility for all Ablynx's...

Vectura Group plc (VEC.L) Appoints Andrew Oakley As Group CFO

Chippenham, UK – 18 November 2014: Vectura Group plc (LSE: VEC; "Vectura" or "the Company"), announces that Andrew J. Oakley, former Chief Financial Officer ("CFO") of Actelion Pharmaceuticals...

Novira Therapeutics Announces Appointment Of Brian F. Daniels, M.D., To Its Scientific Advisory Board

DOYLESTOWN, Pa., Nov. 18, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus...

Trinity Pharma Appoints Dennis Morgan As Chief Financial Officer; Adds Industry Executive, Steven Hirschfeld, To Board Of Directors

Trinity Pharma, a leading provider of cloud-based data and analytics solutions for the global life sciences industry, today announced two key appointments to the company. Technology finance veteran...

Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of James E. Fickenscher to the position of Senior Vice President, Chief Financial Officer. Mr....